Skip to main content
Premium Trial:

Request an Annual Quote

Pressure BioSciences' FY 2009 Revenues Rise 46 Percent

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences said Wednesday that its full-year 2009 revenues increased 46 percent year over year while it cut its net loss nearly in half.

The South Easton, Mass.-based firm brought in total revenues of $1.2 million for 2009 compared to $852,263 for 2008. It reported revenue of $831,602 for its PCT products, services, and other revenue, along with revenue of $413,308 from grants. For 2008, its PCT products, services, and other revenue was $655,252, while its grant revenue was $197,011.

Richard Schumacher, Pressure BioSciences' president and CEO, said that the firm had a significant increase in installations of its PCT Sample Preparation Systems during the year.

"We continue to work towards finding a strategic marketing, sales, and distribution partner for those applications where we believe PCT has significant advantages over competitive sample preparation methods," said Schumacher. "Discussions with several companies are on-going. We continue to believe that we will find at least one, if not more than one, strategic partner in 2010."

Pressure BioSciences' net loss for the year was $2.6 million, or $1.42 per share, compared to a net loss of $4.9 million, or $2.24 per share, for 2008.

Its R&D spending dropped 33 percent to $1.2 million from $1.8 million, while its SG&A spending increased around 12 percent to 42.9 million from $2.6 million.

The firm said that revenues for its fourth quarter were $350,340 compared to $334,041 in the fourth quarter of 2008. Its operating loss for Q4 was $622,000 compared to $800,000 for the comparable period of 2008. The company did not provide any further financial figures for the quarter.

Pressure BioSciences finished the quarter with cash and cash equivalents of $1.6 million.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.